The European Union's drug regulator has recommended approval of Moderna's updated formulation of COVID-19 shot Spikevax, the ...

MRNA's second-quarter results are likely to spotlight a sharp decline in Spikevax sales, RSV uptake and key pipeline ...

Moderna has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use ...

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

Moderna’s Covid vaccine went on to be used globally and has been credited with saving millions of lives. The vaccine pushed Moderna’s annual sales to nearly $20 billion for two years, and its ...

Moderna's COVID-19 vaccine has received full approval from the U.S. Food and Drug Administration (FDA) for use in children with medical conditions that put them at higher risk of severe illness.

If you're confident that its current trials will prove successful, then this is one to buy and sit on. One word of caution ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally intervened to place restrictions on COVID shots from vaccine makers Novavax and ...

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it. It's not a replacement for the company’s existing shot, but a second option.